SCHEMBL29124131

SCHEMBL29124131

Nc1cc2ccccc2c(N2CCC2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NCF1 P14598 4/20 0.50
▸ HPGD P15428 2/20 0.47
▸ L3MBTL1 Q9Y468 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ ATM Q13315 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ TSHR P16473 2/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ GLA P06280 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ MAPT P10636 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ NUDT1 P36639 1/20 0.45
▸ ACP1 P24666 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ CASP1 P29466 1/20 0.43
▸ CASP7 P55210 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4262506 0.95 NCF1 (0.56) NCF1HPGDL3MBTL1KDM4EATM
SCHEMBL177816 0.85 HTR3A (0.61) NCF1KDM4EALDH1A1HTR3AHRH4
SCHEMBL11275047 0.85 NCF1 (0.58) NCF1HPGDKDM4EMAPK1TSHR
SCHEMBL12215244 0.85 HTR2C (0.59) NCF1HPGDKDM4ETSHRHSD17B10
SCHEMBL4770137 0.82 SMN1; SMN2 (0.51) HPGDL3MBTL1TSHRMAPTCYP1A2
SCHEMBL11282819 0.81 ALDH1A1 (0.53) HPGDKDM4EMAPK1TSHRHSD17B10
SCHEMBL26134146 0.79 NCF1 (0.50) NCF1HPGDL3MBTL1KDM4EATM
SCHEMBL25533157 0.76 HPGD (0.52) HPGDL3MBTL1KDM4EATMMAPK1
SCHEMBL11283343 0.74 NCF1 (0.50) NCF1HPGDKDM4EMAPK1TSHR
SCHEMBL26106707 0.71 HTR3A (0.35) NCF1MAPK1TSHRHSD17B10HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117229289-A Preparation and application of EGFR inhibitor with macrocyclic structure 药雅科技(上海)有限公司 2023-12-15 — — CN disclosed
WO-2023174406-A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2023-09-21 — — WO disclosed
Send feedback